SAMUEL RAMMAGE: Open Payments
NPI 1386363489 · HOLLYWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,334 in 55 payments from 13 companies in 2025. Trend: 2023 $1,716 · 2024 $1,706 · 2025 $1,334
Food & beverage: $1,314Education: $20
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 29 | $516 |
| CVRx, Inc. | 1 | $155 |
| United Therapeutics Corporation | 6 | $148 |
| PFIZER INC. | 5 | $118 |
| Medtronic, Inc. | 1 | $109 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $87 |
| ABIOMED | 2 | $71 |
| Novartis Pharmaceuticals Corporation | 2 | $40 |
| Vital Connect, Inc | 1 | $22 |
| Boston Scientific Corporation | 1 | $18 |
Products named: CARDIOMEMS, Barostim Neo System, Tyvaso, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, COREVALVE EVOLUT R, VYNDAQEL, Kerendia, LEQVIO.
Industry payments across FL — which companies pay providers there.
